Preclinical In Vivo Activity of the Menin Inhibitor Ziftomenib (KO-539) in Pediatric KMT2A-Rearranged Acute Lymphoblastic Leukemia

Autor: Falkenstein, Catherine D *, Niswander, Lisa M, Kessler, Linda *, Tomkinson, Blake *, Burrows, Francis *, Tasian, Sarah K
Zdroj: In Blood 15 November 2022 140 Supplement 1:3491-3492
Databáze: ScienceDirect